AbbVie, Inc. (ABBV)
228.49
-1.25
(-0.54%)
USD |
NYSE |
Dec 31, 16:00
230.00
+1.51
(+0.66%)
After-Hours: 20:00
AbbVie Market Cap: 403.83B for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 176.25B |
| Biogen, Inc. | 25.82B |
| Gilead Sciences, Inc. | 152.28B |
| Johnson & Johnson | 498.60B |
| Eli Lilly & Co. | 961.86B |
Market Cap Related Metrics
| PE Ratio | 172.41 |
| PS Ratio | 6.784 |
| Price to Free Cash Flow | 20.56 |
| Price | 228.49 |
| Earnings Yield | 0.58% |
| Operating PE Ratio | 21.24 |
| Normalized PE Ratio | 30.71 |